Teva
TEVA · NYSE
Bulios Fair Price
$36.21
6.0% downside
Current Price
$38.54
According to Bulios Fair Price, TEVA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Teva Pharmaceutical Industries (TEVA) is an Israeli pharmaceutical company specializing in the development, production, and distribution of generic drugs and specialty pharmaceutical products. With a broad portfolio of generic medicines and proprietary products in areas such as neurology, oncology, and respiratory diseases, Teva is one of the largest producers of generic drugs in the world. The company is known for its ability to provide affordable medications and innovative treatment options for patients worldwide. Teva also invests in the research and development of new pharmaceuticals and biologics. Teva Pharmaceutical Industries (TEVA) shares could be suitable for investors looking for opportunities in the pharmaceutical sector with a focus on generic drugs and specialty treatments.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard D. Francis
Employees
32,008
Headquarters
Tel Aviv
Upcoming events
Earnings
Upcoming earnings report